Myobloc Injection, Solution
Product Images NDC 10454-711

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Myobloc (NDC 10454-711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solstice Neurosciences, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Myobloc 01)

An anatomical diagram showing the left side of a human face with labeled injection sites for the masseter muscle, indicated by shaded areas and points marked A, B, and C. The masseter muscle area is labeled 'M' with two shaded regions numbered 1 and 2, illustrating target zones for intramuscular injections likely related to Myobloc (rimabotulinumtoxinB).*

FDA Label Image

Figure 2 (Myobloc 02)

A line graph showing the spontaneous urinary flow rate (USFR) in grams per minute over several weeks post-injection during a double-blind treatment phase. Data are presented for three groups: 3500 U, 2500 U, and placebo, each with 95% confidence intervals. The x-axis represents time points from Day 1 to Week 13; the y-axis shows USFR values from 0.00 to 0.90 g/minute.*

FDA Label Image

Figure 3 (Myobloc 03)

A line graph depicting CGIC scores (scale 1-7) over weeks post-injection during a double-blind treatment phase. Three groups are shown: 3500 U, 2500 U, and placebo, each with 95% confidence intervals. The x-axis represents weeks from W1 to W13.*

FDA Label Image

Principal Display Panel (0.5 mL Vial Carton)

Myobloc 2,500 Units/0.5 mL injection box label featuring rimabotulinumtoxinB for intramuscular and intraglandular use. The teal packaging displays warnings, dosing instructions, and storage directions. Manufactured by Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC, with production at Merz Pharma GmbH & Co. KG in Germany. Includes barcodes and NDC 10454-710-10.*

FDA Label Image

Principal Display Panel (1 mL Vial Carton)

Packaging label for Myobloc rimabotulinumtoxinB injection, 5,000 Units/1 mL, for intramuscular and intraglandular use. The label is purple and prominently displays dosage strength, administration route, and warnings about dosing units. Manufactured by Solstice Neurosciences, LLC. Includes barcodes and storage instructions.*

FDA Label Image

Principal Display Panel (2 mL Vial Carton)

Myobloc 10,000 Units/2 mL (5,000 Units/mL) intramuscular and intraglandular injection packaging label. The box is orange with black text, includes the NDC 10454-712-10, and highlights that dosing units of botulinum toxins are not interchangeable between products. Manufactured by Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC, and produced at Merz Pharma GmbH in Germany. Instructions note refrigeration storage, no preservatives, no freezing or shaking, and dilution with 0.9% sodium chloride injection.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.